|
FI20050695A0
|
|
A process for the preparation of phospholipid-PEG biomolecule conjugates
|
|
FI20041129A0
|
|
Thioxothiazolidinone compounds for use as drugs
|
|
WO2004110478A1
|
|
Inhibitors of cell migration
|
|
FI20040682A0
|
|
Imaging of tumors and metastases using a peptide that has gelatinase
|
|
US2007072251A1
|
|
In vivo imaging using peptide derivatives
|
|
FI20040616A0
|
|
Cellmigrationsinhibitorer
|
|
FI20040572A0
|
|
Inhibitors of matrix metalloproteinase activity
|
|
FI20040558A0
|
|
Pharmaceutical preparation
|
|
FI20031528A0
|
|
A therapeutic liposome composition and a process for its preparation
|
|
FI20030923A0
|
|
Inhibitors of leukocyte pro MMP-9 / beta2 integrin complex
|
|
FI20021726A0
|
|
Process for producing peptides
|
|
HU0303649A2
|
|
Liposome targeting of matrix metalloproteinase inhibitors
|
|
FI20010491A0
|
|
Novel peptide ligands for leukocyte integrins
|
